Alexza Pharmaceuticals Inc
ALXA
ALXA was delisted on the 16th of June, 2016.
31 hedge funds and large institutions have $8.74M invested in Alexza Pharmaceuticals Inc in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 9 closing their positions.
1,893% more call options, than puts
Call options by funds: $1.48M | Put options by funds: $74K
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less funds holding
Funds holding: 38 → 31 (-7)
43% less capital invested
Capital invested by funds: $15.2M → $8.74M (-$6.5M)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$57.5K |
| 2 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$46.4K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.1K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.61K |
| 5 |
SA
SRH Advisors
Salina,
Kansas
|
+$7.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$563K |
| 2 |
FAM
Fortaleza Asset Management
Chicago,
Illinois
|
-$294K |
| 3 |
VM
VHCP Management
New York
|
-$166K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$117K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$111K |
ALXA Hedge Fund Activity: Q4 2014 in Review
31 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q4 2014, worth a combined $8.74M — down 43% from $15.2M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ALXA and 3 opened new positions — a net loss of 6 holders — while 8 trimmed existing stakes and 9 added.
The largest buyer was Geode Capital Management, adding an estimated $57.5K. The largest seller was C WorldWide Group, cutting an estimated $563K.
- 31 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q4 2014, down from 38 in Q3 2014.
- Funds reported $8.74M of Alexza Pharmaceuticals Inc stock for Q4 2014, down 43% quarter-over-quarter.
- 3 funds opened new Alexza Pharmaceuticals Inc positions in Q4 2014 and 9 closed out, a net change of -6 holders.
- The largest Alexza Pharmaceuticals Inc buyer in Q4 2014 was Geode Capital Management, an estimated $57.5K added.
- The largest Alexza Pharmaceuticals Inc seller in Q4 2014 was C WorldWide Group, an estimated $563K sold.
Based on aggregated 13F filings for Q4 2014.